Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-01-2021 | Coronavirus | Brief Report

A mobile DNA laboratory for forensic science adapted to coronavirus SARS-CoV-2 diagnosis

Authors: Patrick Touron, Christian Siatka, Amaury Pussiau, Sébastien Follot, Thibaud Fritz, Mikaël Petit, Noussair Latifa, Jean-Louis Herrmann, Martin Rottman, Antoinette Lemoine, Sylvain Hubac

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2021

Abstract

The Forensic Science Institute of the French “Gendarmerie Nationale” (IRCGN™) developed in 2015 an ISO 17025 certified mobile DNA laboratory for genetic analyses. This Mobil’DNA laboratory is a fully autonomous and adaptable mobile laboratory to perform genetic analyses in the context of crime scenes, terrorism attacks or disasters. To support the hospital task force in Paris during the peak of the COVID-19 epidemic, we adapted this mobile genetic laboratory to perform high-throughput molecular screening for coronavirus SARS-CoV-2 by real-time PCR. We describe the adaptation of this Mobil’DNA lab to assist in Coronavirus SARS-CoV-2 diagnosis.

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536–544. https://doi.org/10.1038/s41564-020-0695-zCrossRef

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5CrossRefPubMedPubMedCentral

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513. https://doi.org/10.1016/S0140-6736(20)30211-7. Accessed 7 may 2020

CDC. Coronavirus Disease 2019 2020 (COVID-19) [Internet]. Centers for Disease Control and Prevention 11 [cited 2020 24]; https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html

de Boer HH, Blau S, Delabarde T, Hackman L (2019) The role of forensic anthropology in disaster victim identification (DVI): recent developments and future prospects. Forensic Sci Res 4:303–315. https://doi.org/10.1080/20961790.2018.1480460CrossRefPubMed

Gaudry E, Dourel L, Conigliaro A, Georget C, Desbrosse X, Hubac S (2017) L’identification de victimes de catastrophe : une approche scientifique pluridisciplinaire. Rev Fr Lab 2017:41–57. http://www.sciencedirect.com/science/article/pii/S1773035X17300291. https://doi.org/10.1016/S1773-035X(17)30029-1CrossRef

Honsa JD, McIntyre DA (2003) ISO 17025: practical benefits of implementing a quality system. J AOAC Int 86:1038–1044CrossRefPubMed

Ho B (2004) Practical application of ISO 15189 by accreditation bodies -: a comparison with ISO/IEC 17025. EJIFCC 15:128–135PubMedPubMedCentral

Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L et al (2020) Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science 368:779–782. https://doi.org/10.1126/science.abb7498CrossRefPubMedPubMedCentral

10.

Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA et al (2020) Virological assessment of hospitalized patients with COVID-2019. Nature 581:465–469. https://doi.org/10.1038/s41586-020-2196-xCrossRefPubMed

11.

Arrêté du 5 avril 2020 complétant l’arrêté du 23 mars 2020 prescrivant les mesures d’organisation et de fonctionnement du système de santé nécessaires pour faire face à l’épidémie de covid-19 dans le cadre de l’état d’urgence sanitaire

Title: A mobile DNA laboratory for forensic science adapted to coronavirus SARS-CoV-2 diagnosis
Authors: Patrick Touron
Christian Siatka
Amaury Pussiau
Sébastien Follot
Thibaud Fritz
Mikaël Petit
Noussair Latifa
Jean-Louis Herrmann
Martin Rottman
Antoinette Lemoine
Sylvain Hubac
Publication date: 01-01-2021
Publisher: Springer Berlin Heidelberg
Keywords: Coronavirus
SARS-CoV-2
COVID-19
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-020-03989-3

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

One-pot biosynthesis of silver nanoparticles with potential antimicrobial and antibiofilm efficiency against otitis media–causing pathogens

Factors affecting the discharge of patients from hospital with seasonal influenza—the role of the Rapid Influenza testing in hospital discharges

Irrelevance of Panton-Valentine leukocidin in hidradenitis suppurativa: results from a pilot, observational study

Citrobacter telavivum sp. nov. with chromosomal mcr-9 from hospitalized patients

TDM-guided medication of polymyxin B in a patient with CRKP-induced bloodstream infection: a case report

Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage